What happens if I stop taking Prolia?
Here's the point
Stopping Prolia (denosumab) isn't a neutral event. Because it doesn't build up in your bones the way bisphosphonates do, its protective effect wears off once doses stop. This can lead to a rapid rebound in bone turnover and a risk of multiple vertebral fractures, sometimes within months — so this is a decision to make with your prescriber, not on your own.
Denosumab works by blocking RANKL, a signal that tells osteoclasts (the cells that break down bone) to mature and get to work. By calming this process, it reduces how much bone is removed, which lets bone formation get ahead and lowers fracture risk substantially in trials. It's given as a twice-yearly injection.
The key difference from bisphosphonates is that denosumab doesn't stay stored in bone tissue. That means once you stop taking it, or miss doses, its effect doesn't linger — it simply ends. This is well documented in clinical research and guidelines, and it's considered one of the most important things for anyone on this medication to understand.
What makes this especially important is the rebound effect: stopping without transitioning to another treatment has been linked to a fast increase in bone turnover and a risk of multiple vertebral fractures, sometimes within just a few months of the last dose.
If you're on Prolia and thinking about stopping, missing a dose, or wondering what comes next, the right move is to talk with your physician first. They can walk you through what to monitor and what transition plan, if any, makes sense for your situation. It's also worth asking them how long you're expected to stay on it and what the plan is at the end.
Know these words
Denosumab (Prolia) is a twice-yearly injection that blocks RANKL, a signal osteoclasts need to mature, slowing bone…
RANKL is a signal that activates osteoclasts, the cells that break down bone, and it's a key target for some…
Antiresorptive medications, like bisphosphonates and denosumab, slow down the cells that break down old bone,…
A drug holiday is a temporary, prescriber-guided pause from a bisphosphonate medication after several years of use,…
A fragility fracture is a broken bone caused by a fall or bump that normally wouldn't break a healthy bone, often at…
Bisphosphonates are osteoporosis medications — like alendronate, risedronate, and zoledronic acid — that slow down…
How sure is this?
Graded Strong Clinical Evidence: Supported by multiple well-designed clinical studies in humans. Read each study with its grade in mind. One study is a piece of the picture, not the whole of it.
The lessons behind this answer
More on medications and hormones
Bone medications generally work in one of two ways: they either slow down the cells that break down old bone (antiresorptives), or they actively stimulate the cells that build new bone (anabolics). Which family your drug belongs to tells you a lot about what it can realistically do, and that's worth asking your prescriber about directly.
Read the full answer →That's a decision for you and your prescriber, not something OsteoStrong changes. Medication and mechanical loading work on different parts of the same system — your drug manages the chemical signalling of bone remodeling, while loading supplies a mechanical stimulus along with muscle, balance and coordination. They're meant to work alongside each other, not replace one another.
Read the full answer →Yes, it's possible — a number of common medications can affect bone, so it's a smart question to ask. This doesn't mean you should change anything on your own; it just means it's worth reviewing your full medication list with your prescriber to understand whether bone monitoring makes sense for you.
Read the full answer →Whether hormone therapy is right for your bones is a decision only you and your prescriber can make, based on your personal history — but it's worth knowing the evidence on hormones and bone is actually strong and has often been misrepresented, which is likely why your doctor is being careful. The caution usually traces back to one 2002 trial that was widely misreported; since then, the understanding has shifted considerably, especially around a woman's age and timing when therapy starts.
Read the full answer →Have a question that isn't here? Ask us at your next visit, or ask our AI bone health advisor.
Education only, not medical advice. Decisions about tests, medications and treatment belong with your own doctor. OsteoStrong does not diagnose, treat or cure any disease.
